NFE2L2 and acute myeloid leukemia: By using various ferroptosis inducers and inhibitors, they have shown that NRF2-deficient AML cells are particularly sensitive to ferroptosis inducers and that NRF2-induced GPX4 supports AML cell survival against drug treatment.